Hepatic steatosis and vascular disease

European Review for Medical and Pharmacological Sciences

Volumn 9, Issue 5, 2005, Pages 269-271

  Santoliquido, A ^a   Di Campli, C ^a   Miele, L ^a   Gabrieli, M L ^a   Forgione, A ^a   Zocco, M A ^a   Lupascu, A ^a   Di Giorgio, A ^a   Flore, R ^a   Pola, P ^a   Gasbarrini, G ^a   Gasbarrini, A ^a   Tondi, P ^a   Grieco, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Atherosclerosis; Cardiovascular disease; Endothelium; Inflammation; Metabolic syndrome; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISEASE COURSE; ENDOTHELIUM LESION; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; ISCHEMIC HEART DISEASE; METABOLIC SYNDROME X; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREVALENCE; RISK FACTOR; STROKE;

ANIMALS; CARDIOVASCULAR DISEASES; FATTY LIVER; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; OXIDATIVE STRESS;

EID: 25844530781     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Angulo P. Non-alcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231.
2. Falck-Ytter Y, Younussi ZM, Marchesini G, Mc Collough AJ. Clinical features and natural history of non-alcoholic steatosis syndromes. Semin Liv Dis 2001; 21: 17-26.
3. Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of non-alcoholic fatty liver disease to insulin resistance. Am J Med 1999; 107: 450-455.
4. Dandona P, Aliada A, Mohanty P, et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 2001; 86: 3257-3265.
5. Bugianesi E, Zannoni C, Vanni E, Marzocchi R, Marchesini G. Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship? Dig Liv Dis 2004; 36: 165-173.
6. Bugianesi E, Gastaldelli A, Vanni E, et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 2005; 48: 634-642.
7. Ninomiya JK, L'Italien G, Criqui MH, White JL, Gamst A, Chen RS. Association of metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation, 2004; 109: 42-46.
8. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
9. Bonora E, Kiechil S, Willeit J, et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome. Diabetes Care 2003; 26: 1251-1257.
10. Olijhoek JK, van der Graaf Y, Banga JD, et al. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J 2004; 25: 342-348.
11. McNeil AM, Rosamond WD, Girman CJ, et al. Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC study). Am J Cardiol 2004; 94: 1249-1254.
12. Unger RH. Lipotoxic diseases. Annu Rev Med 2002; 53: 319-336.
13. Madamanchi EN, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005; 25: 29-38.
14. Deedwania PC. Metabolic syndrome and vascular disease. Is nature or nurture leading the epidemic of cardiovascular disease? Circulation 2004: 109: 2-4.
15. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incidente cardiovascular events. An 8 year follow-up of 14719 initially healthy american women. Circulation 2003; 107: 391-397.
16. Kerner A, Avizohar O, Sella R, et al. Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome. Arterioscler Thromb Vasc Biol 2005; 25-193-197.
17. Arcaro G, Cretti A, Balzano S, et al. Insulin causes endothelial dysfunction in humans. Sites and mechanisms. Circulation 2002; 105: 576-582.